List view / Grid view
Analysis cites personalised medicine, outsourcing and digitalisation as some of the key factors set to advance the pharmaceutical analytical testing market to 2032.
As the outsourcing market evolves, pharmaceutical businesses are reassessing their strategies to better insulate themselves against the pressure of compounding macroeconomic constraints, including a looming patent cliff, rising costs and developmental risks. Sponsors are adopting more intelligent, blended models that seamlessly integrate functional service provision (FSP), full-service outsourcing (FSO), standalone…
Pharmacovigilance regulation in the EU and beyond has continued to grow and become more stringent over the last decade. In this article, ICON’s Graeme Bones explains how to handle the different types of data migration methods and how companies can select the optimum approach to ensure data integrity is maintained.
Welcome to EPR's Guide to Data Integrity. In this edition, Charles River explores the significance of data integrity in pharmaceutical manufacturing, Graeme Bones of ICON considers how to complete database transfer with data integrity considerations at the forefront and Rapid Micro Biosystems® discusses the practical implications of the ‘four-eyes principle’ for pharma…
Research suggests outsourcing and the increasing incidence of adverse drug reactions (ADR) will be primary drivers of growth in the global pharmacovigilance market.
A new report suggests the global biotechnology and pharmaceutical services outsourcing market will grow because of the pandemic and rising drug development costs and R&D investments.
Dr Caroline Forkin from ICON discusses the current status of HIV treatments and potential for researchers to develop a vaccine.
27 December 2011 | By ICON plc
ICON plc., has announced the retirement of Non-Executive Director, Dr. Anthony Murphy to become effective on 31st December 2011...
12 December 2011 | By ICON plc
ICON plc, has agreed, subject to closing conditions, to acquire BeijingWits Medical Consulting Ltd., a leading CRO in China...
21 October 2011 | By ICON plc
ICON has announced it has received a contract award from the Foundation for the National Institutes of Health (FNIH)...
17 October 2011 | By Weber Shandwick
ICON plc, announced the appointment of Colin Stanley as President of DOCS, the company’s global resourcing division...
31 August 2011 | By ICON plc
Agreement builds on existing strategic partnership for global clinical development...
14 July 2011 | By ICON plc
ICON plc, announced the acquisition of Firecrest Clinical, a market-leading provider of technology solutions that boost investigator site performance and study management...
26 May 2011 | By ICON plc
ICON plc has announced a strategic partnership with Pfizer Inc...
14 July 2010 | By Weber Shandwick
ICON plc, announced the appointment of...
